Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 60Terminated 11Withdrawn 4Unknown 4Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 362Glioblastoma 299Glioma 239Neuroblastoma 95Neoplasms 70Central Nervous System Neoplasms 62Astrocytoma 61Meningioma 59Breast Neoplasms 51Lung Neoplasms 46Carcinoma, Non-Small-Cell Lung 46Melanoma 40Sarcoma 35Medulloblastoma 33Meningeal Carcinomatosis 32Recurrence 31Neoplasm Metastasis 28Diffuse Intrinsic Pontine Glioma 28Prostatic Neoplasms 27Pheochromocytoma 26Paraganglioma 26Neurofibromatosis 1 26Pancreatic Neoplasms 24Ovarian Neoplasms 24Oligodendroglioma 22Ependymoma 21Osteosarcoma 20Head and Neck Neoplasms 20Spinal Cord Neoplasms 19Kidney Neoplasms 19

Interventions

Vincristine 1Endostatins 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Optic Nerve Glioma × CNS × Clear all
NCT04648462 2024-11-26

Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

Maastricht Radiation Oncology

Recruiting
1,500 enrolled
CNS

Adenoma, Astrocytoma, Craniopharyngioma, Ependymoma, Hemangiopericytoma, Meningioma, Neurilemmoma, Oligodendroglioma, Germinoma, Ganglioglioma, Nerve Sheath Neoplasms, Optic Nerve Glioma

NCT05278715 2024-10-15

Modified CV Regimen in Optic Pathway Glioma

Beijing Sanbo Brain Hospital

Phase 2 Recruiting
75 enrolled
CNS

Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡